Myostatin
Myostatin is a signal released by muscle that limits how much muscle you can build; training and protein lower it, and blocking it is being tested as a way to lose fat without losing muscle.
Plain English
Patient-Friendly Explanation
Muscle is not just padding - it is an organ that burns energy, stores protein and releases signals that talk to the rest of the body. Myostatin is one of those signals, and its job is to put a brake on muscle growth. Animals and people with a faulty myostatin gene end up unusually muscular, which is how the brake was first discovered. Why it matters during weight loss is simple: when you lose weight quickly - through very low calorie diets or the newer injection medicines - a large part of what leaves is muscle, not fat. In some studies a quarter to nearly half of the total weight lost was lean tissue, and losing muscle slows your resting metabolism, weakens grip and walking speed and makes weight regain more likely. Myostatin rises with obesity and after severe energy restriction, so the brake gets stronger just when you need muscle most. Two things push back: lifting something heavy two or three times a week, and eating enough protein, roughly 1.2 to 1.6 grams per kilogram of body weight a day. Drugs that block myostatin are in development and have shown fat loss with muscle preservation in early trials, but they are not yet standard treatment.
Medical
Clinical Definition
Myostatin (GDF-8) is a transforming growth factor-beta superfamily member secreted by skeletal muscle that negatively regulates myogenesis, binding the activin type IIB receptor to activate SMAD2/3 signalling, inhibit MyoD and myogenin and suppress mammalian target of rapamycin activity, thereby limiting myoblast differentiation and muscle protein synthesis. Loss-of-function mutations produce hypermuscularity in cattle, sheep, dogs and humans. Expression is regulated by mechanical loading, glucocorticoids, androgens and inflammation, and circulating levels are elevated in obesity, insulin resistance and after very low-energy diets, when muscle protein breakdown accelerates. In weight-management practice the clinical relevance is lean mass preservation: diet-induced weight loss typically comprises 20-30% lean tissue, and higher proportions are seen with rapid loss in older or sarcopenic patients, contributing to reduced resting energy expenditure and weight regain. Resistance training combined with 1.2-1.6 g/kg/day protein attenuates loss of lean mass. Myostatin or activin blockade (for example bimagrumab or follistatin) increases lean mass and reduces fat mass in trials, and combination with incretin therapy has been studied specifically to protect muscle during pharmacologic weight loss; long-term safety and outcomes are still unproven.
Key Insight
Why It Matters
When we talk about weight, we also talk about what kind of weight you are losing. A scale cannot tell the difference between fat and muscle, so a fast drop that leaves you weaker is not a win. The two reliable levers are resistance training two or three times a week and enough protein - a palm-sized portion at each meal is a decent starting rule - and both lower the myostatin brake. If you are using appetite-suppressing medication or a very low calorie plan, protecting muscle matters even more, and we track grip strength, waist and how your clothes fit rather than the scale alone.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: September 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
